Southern Acids (malaysia) Bhd. · MYX:SAB
Southern Acids (malaysia) Bhd — Southern Acids (M) Berhad — Shareholder Meeting (September 2013)
19 slides from Southern Acids (malaysia) Bhd's shareholder meeting presentation, Sep 26, 2013
Slide 1: Shareholders' Briefing - 32nd Annual General Meeting
SOUTHERN ACIDS (M) BERHAD Shareholders’ Briefing 32nd Annual General Meeting 26 September 2013
Slide 2: Disclaimer Notice
Disclaimer Notice This presentation may contain projections and forward looking statements. Such statements are based on current circumstances and assumptions which may change over time. Accordingly no reliance should be placed on any of these projections and forward looking statements, express or i
Slide 3: Presentation Contents
Presentation Contents 1. Operating Business Segments 2. Southern Acids (M) Berhad and its subsidiaries (“Southern Acids”) Financial Highlights 3. Review of Major Operations 4. Southern Acids 5 Year Profit Before Tax 5. Prospects 2
Slide 4: Business Divisions
BUSINESS DIVISIONS Oleochemicals Operating Plantations & Milling Business Divisions Healthcare Warehousing & Conveying 3
Slide 5: Southern Acids Financial Highlights
Southern Acids Financial Highlights 4
Slide 6: Southern Acids Financial Results Year Ended March
SOUTHERN ACIDS FINANCIAL RESULTS YEAR ENDED 31 MARCH 2013 (RM’000) 2012 (RM’000) Change Revenue 581,425 560,876 3.7% Profit before tax 56,881 41,275 37.8% Profit for the year 45,635 28,014 62.9% Attributable to equity holders of 36,616 19,924 83.8% the Company Earnings per share 26.74 sen 14.55 sen
Slide 7: Southern Acids Financial Position Year Ended March
SOUTHERN ACIDS FINANCIAL POSITION YEAR ENDED 31 MARCH 2013 (RM’000) 2012 (RM’000) Change Total Assets 549,359 512,004 7.3% Total Liabilities 66,604 60,804 9.5% Net Current Assets 192,415 159,258 20.8% Equity Attributable to Shareholders’ of the 446,783 420,584 6.2% Company Net Assets 482,755 451,200
Slide 8: Southern Acids Revenue and Profit Before Tax
Southern Acids Revenue and Profit Before Tax Year Ended 2013 and 2012 (in RM’000) 3.7% 581,425 560,876 600,000 500,000 400,000 300,000 200,000 37.8% 100,000 56,881 - 41,275 Revenue Revenue 2013 PBT 2013 2012 PBT 2012 Southern Acids revenue was marginally higher in financial year (“FY”) 2013 due main
Slide 9: Revenue by Business Divisions
Revenue by Business Divisions Year Ended 2013 and 2011(RM’000) 400,000 375,447 376,282 Oleochemicals 0.22% 300,000 Plantations & Milling 18.32% 200,000 Healthcare 122,314 103,375 6.00% 100,000 72,872 6,896 68,746 Warehousing & Conveying - 3,896 8,066 14.51% 4,407 Others FY 2013 11.60% FY 2012 Saved
Slide 10: Profit/(Loss) Before Tax by Business Divisions
Profit/ (Loss) Before Tax by Business Divisions (RM’000) 35,000 32,540 Oleochemicals 30,000 119.55% 23,180 26,195 25,000 Plantations & Milling 20,000 24.22% 15,000 Healthcare 10,558 10,000 16.67% 3,836 5,000 3,288 Warehousing & 1,838 2,956 Conveying - 37.82% (5,000) FY 2013 Others (4,513) FY 2012 (1
Slide 11: Review Of Major Operations
Review Of Major Operations 10
Slide 12: Review of Major Operations: Oleochemicals
Review of Major Operations 400,000 0.22% Oleochemicals 350,000 Revenue were consistent at about the RM375 million level for the two FYs under 300,000 review in spite of the lower average selling prices of fatty acids and glycerine in FY2013. 250,000 FY2013 revenue were bolstered/ held up by 375,44
Slide 13: Review of Major Operations: Plantations & Milling
Review of Major Operations 140,000 18.32% Plantations & Milling 120,000 • Both revenue and profit before tax profit were higher in FY2013 compared to FY 100,000 122,314 2012 driven primarily by increased sales/ 80,000 24.22% production volume and better fresh fruit bunches (FFBs) yield from the divi
Slide 14: Review of Major Operations: Healthcare
Review of Major Operations RM’000 Healthcare 6.00% 80,000 72,872 68,746 Revenue for FY2013 was 6% higher at 70,000 RM72.872 million against the RM68.746 million recorded in FY2012 due mainly to higher 60,000 inpatient census and income per patient recorded in FY2013 against FY2012. 50,000 40,000
Slide 15: Review of Major Operations: Warehouse & Conveying
Review of Major Operations RM’000 Warehouse & Conveying 9,000 14.51% 8,066 • Both revenue and profit before tax 8,000 6,896 from the warehousing and conveying 7,000 division were lower in FY2013 mainly because of lower volume of PKE received 6,000 into its warehouse and cargo handled by 5,000 its co
Slide 16: Southern Acids 5 Year Profit Before Tax
Southern Acids 5 Year Profit Before Tax (RM’000) 60,000 55,460 56,881 50,000 41,275 40,000 30,721 30,000 20,000 4,321 10,000 - 2009 2010 2011 2012 2013 15
Slide 17: Prospects
Prospects • Oleochemicals We expect the plant will continue to run at full capacity as forecasted demand will continue to exceed the plant’s production capacity. The division’s performance will hinge significantly on the volatility in prices of key raw materials and the USD/ MYR exchange rate. Going
Slide 18: Prospects
Prospects • Healthcare Division Going forward, we expect revenue from the Healthcare division to increase gradually from FY2014 on in line with the division’s on- going plans to increase the number of consultants and medical discipline at the Hospital. Profitability though is expected to grow at a s
Slide 19: Questions & Answers
Questions & Answers Thank you 18
Southern Acids (M) Berhad — Shareholder Meeting (September 2013) on 6ix